Mesenchymal stem cells prevent the rejection of fully allogenic islet grafts by the immunosuppressive activity of matrix metalloproteinase-2 and -9.

OBJECTIVE Mesenchymal stem cells (MSCs) are known to be capable of suppressing immune responses, but the molecular mechanisms involved and the therapeutic potential of MSCs remain to be clarified. RESEARCH DESIGN AND METHODS</...

Cijeli opis

Bibliografski detalji
Glavni autori:	Ding, Y, Xu, D, Feng, G, Bushell, A, Muschel, R, Wood, K
Format:	Journal article
Jezik:	English
Izdano:	American Diabetes Association 2009

Slični predmeti

Mesenchymal stem-cell immunosuppressive capabilities: therapeutic implications in islet transplantation.
od: Ding, Y, i dr.
Izdano: (2010)

Intrathymic inoculation of donor B cells induced indefinite prolongation of fully allogeneic cardiac grafts but not islet or skin grafts.
od: Niimi, M, i dr.
Izdano: (2000)

Ras, metastasis, and matrix metalloproteinase 9.
od: Bernhard, E, i dr.
Izdano: (2001)

In vivo generated CD25(+)CD4(+) T cells regulate islet allograft rejection by preventing effector cell migration into the graft
od: Bortecen, K, i dr.
Izdano: (2005)

Overexpression of heme oxygenase-1 protects allogeneic thyroid grafts from rejection in naive mice.
od: Niimi, M, i dr.
Izdano: (2000)

CD52 antibodies for prevention of graft-versus-host disease and graft rejection following transplantation of allogeneic peripheral blood stem cells.
od: Hale, G, i dr.
Izdano: (2000)

Regulation of matrix metalloproteinase-9 (MMP-9) by translational efficiency in murine prostate carcinoma cells.
od: Jiang, Y, i dr.
Izdano: (2002)

Mesenchymal stem cell-mediated T cell immunosuppression
od: Al-Graittee, Satar Jabbar Rahi, i dr.
Izdano: (2017)

Matrix metalloproteinase-9 regulates tumor cell invasion through cleavage of protease nexin-1.
od: Xu, D, i dr.
Izdano: (2010)

Transplantation of human islets without immunosuppression
od: Colton, Clark K., i dr.
Izdano: (2014)

Matrix metalloproteinase 9 promoter activity is induced coincident with invasion during tumor progression.
od: Kupferman, M, i dr.
Izdano: (2000)

Adverse outcome of human islet-allogeneic blood interaction.
od: Titus, T, i dr.
Izdano: (2003)

Matrix metalloproteinase-9 in patients with acute coronary syndrome.
od: Lee, R
Izdano: (2012)

Role of matrix metalloproteinase 9 in pituitary tumor behavior.
od: Turner, H, i dr.
Izdano: (2000)

Mesenchymal stromal cells in transplantation rejection and tolerance.
od: English, K, i dr.
Izdano: (2013)

Mesenchymal stem cell mediated immunosuppression is not confined to progenitor status
od: Jones, F, i dr.
Izdano: (2007)

Tumor epithelial cell matrix metalloproteinase 9 is a target for antimetastatic therapy in colorectal cancer.
od: Lubbe, W, i dr.
Izdano: (2006)

Hyperthermic preconditioning protects pig islet grafts from early inflammation but enhances rejection in immunocompetent mice.
od: Brandhorst, D, i dr.
Izdano: (2003)

Role of T cells in graft rejection and transplantation tolerance.
od: Issa, F, i dr.
Izdano: (2010)

Characterisation and immunosuppressive activity of human cartilage-derived mesenchymal stem cells
od: Ramasamy, Rajesh, i dr.
Izdano: (2018)

Matrix metalloproteinases in cancer.
od: Itoh, Y, i dr.
Izdano: (2002)

Matrix metalloproteinases 3 and 9 and loss of perineuronal nets in Alzheimer's disease
od: Baig, S, i dr.
Izdano: (2006)

Selective hydrolysis of triple-helical substrates by matrix metalloproteinase-2 and -9.
od: Lauer-Fields, J, i dr.
Izdano: (2003)

Heparin administration leads to rapid decrease in plasma matrix metalloproteinase-9
od: Lee, R, i dr.
Izdano: (2013)

Heparin administration leads to rapid decrease in plasma matrix metalloproteinase-9.
od: Lee, R, i dr.
Izdano: (2013)

Functional polymorphism in matrix metalloproteinase-9 gene associated with coronary atherosclerosis
od: Ye, S, i dr.
Izdano: (2000)

Epithelial-to-Mesenchymal Transition Contributes to Immunosuppression in Breast Carcinomas
od: Rashidian, Mohammad, i dr.
Izdano: (2018)

Guanylyl cyclase C prevents colon cancer metastasis by regulating tumor epithelial cell matrix metalloproteinase-9.
od: Lubbe, W, i dr.
Izdano: (2009)

CD25+CD4+ regulatory T cells prevent graft rejection: CTLA-4- and IL-10-dependent immunoregulation of alloresponses.
od: Kingsley, C, i dr.
Izdano: (2002)

Splenic mesenchyme-to-epithelial transition in islet neogenesis
od: Robertson, S, i dr.
Izdano: (2009)

Caprine pancreatic islet xenotransplantation into diabetic immunosuppressed BALB/c mice
od: Hani, Homayoun, i dr.
Izdano: (2014)

Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry.
od: Visse, R, i dr.
Izdano: (2003)

Progress in matrix metalloproteinase research.
od: Murphy, G, i dr.
Izdano: (2008)

Differential susceptibility of heart, skin, and islet allografts to T cell-mediated rejection.
od: Jones, N, i dr.
Izdano: (2001)

The competency of foregut mesenchyme in islet mesenchyme-to-epithelial transition during embryonic development.
od: Teague, W, i dr.
Izdano: (2006)

Preferential inactivation of tissue inhibitor of metalloproteinases-1 that is bound to the precursor of matrix metalloproteinase 9 (progelatinase B) by human neutrophil elastase.
od: Itoh, Y, i dr.
Izdano: (1995)

Claudin promotes activation of pro-matrix metalloproteinase-2 mediated by membrane-type matrix metalloproteinases.
od: Miyamori, H, i dr.
Izdano: (2001)

Kinetics of transplant arteriosclerosis in MHC-Class I mismatched and fully allogeneic mouse aortic allografts.
od: Ensminger, S, i dr.
Izdano: (2002)

Association of matrix metalloproteinase-1, 9, 12 and tissue inhibitor of metalloproteinase-1 gene polymorphisms in malay male essential hypertensive subject
od: Tabatabaee, Farizeh Aalam Ghomi
Izdano: (2015)

Plasma levels of matrix metalloproteinase-2 and -9 (MMP-2 and MMP-9) in age-related macular degeneration.
od: Chau, K, i dr.
Izdano: (2007)